AG2R LA Mondiale Gestion D Actifs bought a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The fund bought 13,394 shares of the financial services provider's stock, valued at approximately $3,871,000.
Several other large investors have also recently made changes to their positions in CME. Bank Pictet & Cie Europe AG lifted its stake in shares of CME Group by 29.0% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 86,941 shares of the financial services provider's stock valued at $20,190,000 after purchasing an additional 19,533 shares during the period. Lighthouse Investment Partners LLC acquired a new position in CME Group during the fourth quarter worth $551,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in CME Group by 5.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 64,586 shares of the financial services provider's stock worth $14,999,000 after acquiring an additional 3,618 shares during the period. NorthRock Partners LLC acquired a new position in CME Group during the fourth quarter worth $810,000. Finally, Man Group plc raised its position in CME Group by 13.0% during the fourth quarter. Man Group plc now owns 192,020 shares of the financial services provider's stock worth $44,593,000 after acquiring an additional 22,049 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
CME has been the subject of a number of research analyst reports. UBS Group reduced their price objective on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Finally, Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the company's stock. According to MarketBeat, CME Group currently has a consensus rating of "Hold" and a consensus price target of $260.60.
View Our Latest Stock Analysis on CME
Insider Activity
In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the completion of the transaction, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. This trade represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William R. Shepard bought 256 shares of the stock in a transaction on Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, with a total value of $69,255.68. Following the purchase, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.30% of the company's stock.
CME Group Trading Up 0.3%
Shares of CME traded up $0.71 during mid-day trading on Wednesday, reaching $260.54. The stock had a trading volume of 588,453 shares, compared to its average volume of 2,283,744. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 52-week low of $212.38 and a 52-week high of $290.79. The business's fifty day moving average is $272.81 and its 200 day moving average is $270.55. The firm has a market cap of $93.89 billion, a price-to-earnings ratio of 25.37, a P/E/G ratio of 4.69 and a beta of 0.43.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.56 earnings per share. On average, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.